HEALTHCARE TRIANGLE INC (HCTI) Stock Fundamental Analysis

NASDAQ:HCTI • US42227W3060

3.52 USD
-0.62 (-14.98%)
At close: Mar 2, 2026
3.4155 USD
-0.1 (-2.97%)
After Hours: 3/2/2026, 8:25:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HCTI. HCTI was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of HCTI have multiple concerns. HCTI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year HCTI has reported negative net income.
  • In the past year HCTI has reported a negative cash flow from operations.
  • HCTI had negative earnings in 4 of the past 5 years.
  • In the past 5 years HCTI always reported negative operating cash flow.
HCTI Yearly Net Income VS EBIT VS OCF VS FCFHCTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • HCTI has a Return On Assets of -45.69%. This is in the lower half of the industry: HCTI underperforms 65.71% of its industry peers.
  • Looking at the Return On Equity, with a value of -72.30%, HCTI is doing worse than 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -45.69%
ROE -72.3%
ROIC N/A
ROA(3y)-159.11%
ROA(5y)-96.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCTI Yearly ROA, ROE, ROICHCTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • Looking at the Gross Margin, with a value of 13.11%, HCTI is doing worse than 88.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HCTI has grown nicely.
  • HCTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y3.95%
HCTI Yearly Profit, Operating, Gross MarginsHCTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HCTI has more shares outstanding
  • The number of shares outstanding for HCTI has been increased compared to 5 years ago.
  • The debt/assets ratio for HCTI is higher compared to a year ago.
HCTI Yearly Shares OutstandingHCTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
HCTI Yearly Total Debt VS Total AssetsHCTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of 1.24, we must say that HCTI is in the distress zone and has some risk of bankruptcy.
  • HCTI has a Altman-Z score (1.24) which is in line with its industry peers.
  • HCTI has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • HCTI has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: HCTI outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC9.27%
HCTI Yearly LT Debt VS Equity VS FCFHCTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • HCTI has a Current Ratio of 2.03. This indicates that HCTI is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.03, HCTI perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
  • A Quick Ratio of 1.98 indicates that HCTI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.98, HCTI is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.98
HCTI Yearly Current Assets VS Current LiabilitesHCTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.53% over the past year.
  • Looking at the last year, HCTI shows a very negative growth in Revenue. The Revenue has decreased by -21.88% in the last year.
  • HCTI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.46% yearly.
EPS 1Y (TTM)81.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.22%
Revenue 1Y (TTM)-21.88%
Revenue growth 3Y-30.78%
Revenue growth 5Y-16.46%
Sales Q2Q%44.59%

3.2 Future

  • Based on estimates for the next years, HCTI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.35% on average per year.
  • HCTI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -12.97% yearly.
EPS Next Y-1933.33%
EPS Next 2Y-142.67%
EPS Next 3Y-34.71%
EPS Next 5Y43.35%
Revenue Next Year-72.5%
Revenue Next 2Y-36.88%
Revenue Next 3Y-21.81%
Revenue Next 5Y-12.97%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCTI Yearly Revenue VS EstimatesHCTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
HCTI Yearly EPS VS EstimatesHCTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • HCTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCTI Price Earnings VS Forward Price EarningsHCTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCTI Per share dataHCTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • A cheap valuation may be justified as HCTI's earnings are expected to decrease with -34.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-142.67%
EPS Next 3Y-34.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HCTI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HEALTHCARE TRIANGLE INC

NASDAQ:HCTI (3/2/2026, 8:25:22 PM)

After market: 3.4155 -0.1 (-2.97%)

3.52

-0.62 (-14.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners10.88%
Inst Owner Change31.41%
Ins OwnersN/A
Ins Owner Change0%
Market Cap37.88M
Revenue(TTM)12.94M
Net Income(TTM)-6.32M
Analysts82.86
Price Target306 (8593.18%)
Short Float %N/A
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5900%
PT rev (3m)5900%
EPS NQ rev (1m)-5900%
EPS NQ rev (3m)-5900%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.93
P/FCF N/A
P/OCF N/A
P/B 4.33
P/tB 13.28
EV/EBITDA N/A
EPS(TTM)-103.12
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-1.1
FCFYN/A
OCF(TTM)-0.98
OCFYN/A
SpS1.2
BVpS0.81
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.69%
ROE -72.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.11%
FCFM N/A
ROA(3y)-159.11%
ROA(5y)-96.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.08%
GM growth 5Y3.95%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.98
Altman-Z 1.24
F-Score3
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.22%
EPS Next Y-1933.33%
EPS Next 2Y-142.67%
EPS Next 3Y-34.71%
EPS Next 5Y43.35%
Revenue 1Y (TTM)-21.88%
Revenue growth 3Y-30.78%
Revenue growth 5Y-16.46%
Sales Q2Q%44.59%
Revenue Next Year-72.5%
Revenue Next 2Y-36.88%
Revenue Next 3Y-21.81%
Revenue Next 5Y-12.97%
EBIT growth 1Y36.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.51%
OCF growth 3YN/A
OCF growth 5YN/A

HEALTHCARE TRIANGLE INC / HCTI FAQ

Can you provide the ChartMill fundamental rating for HEALTHCARE TRIANGLE INC?

ChartMill assigns a fundamental rating of 2 / 10 to HCTI.


Can you provide the valuation status for HEALTHCARE TRIANGLE INC?

ChartMill assigns a valuation rating of 0 / 10 to HEALTHCARE TRIANGLE INC (HCTI). This can be considered as Overvalued.


How profitable is HEALTHCARE TRIANGLE INC (HCTI) stock?

HEALTHCARE TRIANGLE INC (HCTI) has a profitability rating of 1 / 10.


How financially healthy is HEALTHCARE TRIANGLE INC?

The financial health rating of HEALTHCARE TRIANGLE INC (HCTI) is 3 / 10.